Veracyte to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced it will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026, at 7:00 a.m. Eastern Time.
Covered in this story
What has happened since
- Morgan Stanley is down 12.8% since this was published, 51 days ago.
- Veracyte Inc is up 6.0% since this was published, 51 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Morgan Stanley
- Morgan Stanley: $216 → $215 by Jul 2027 via GuruFocus
- RBC Capital Markets: $211 → $243 by Jul 2027 · Sector Perform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $MS yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Morgan Stanley →Dalsna Finance is currently tracking 53 stories mentioning Morgan Stanley, the earliest published 23 Mar 2026.
Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.